Papillary thyroid cancer natural history, complications and prognosis

Revision as of 17:46, 4 November 2015 by Ammu Susheela (talk | contribs)
Jump to navigation Jump to search

Papillary thyroid cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Papillary thyroid cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Papillary thyroid cancer natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Papillary thyroid cancer natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Papillary thyroid cancer natural history, complications and prognosis

CDC on Papillary thyroid cancer natural history, complications and prognosis

Papillary thyroid cancer natural history, complications and prognosis in the news

Blogs on Papillary thyroid cancer natural history, complications and prognosis

Directions to Hospitals Treating Papillary thyroid cancer

Risk calculators and risk factors for Papillary thyroid cancer natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Natural History

Complications

Prognosis

  • Prognosis of patients with papillary thyroid cancer is found to be dependent on the patient's age, size of the tumor, presence of metastatic disease, and presence of tumor invasion into adjacent tissues near the thyroid gland.

Depending on source, the overall 5-year survival rate for papillary thyroid cancer is 96 percent[1] or 97 percent,[2] with a 10-year survival rate of 93 percent.[1]

For a more specific prognosis for individual cases, there are at minimum 13 known scoring systems for prognosis; among the more often used are:

  • AGES - Age, Grade, Extent of disease, Size
  • AMES - Age, Metastasis, Extent of disease, Size
  • MACIS - Metastasis, Age at presentation, Completeness of surgical resection, Invasion (extrathyroidal), Size[3] (this is a modification of the AGES system). It is probably the most reliable staging method available. Also known as the MAICS system.
  • TNM staging - Tumor, node, metastasis. Remarkable about the TNM staging for (differentiated) thyroid carcinoma is that the scoring is different according to age.

MACIS

The MACIS system of estimating the prognosis of papillary thyroid cancer was developed by Clive S. Grant at the Mayo Clinic, and was based on careful evaluation of a large group of patients. It is probably the most reliable staging method available.[4]

It assigns scores to the main factors involved, and uses the sum of this score to calculate the prognosis:

Factors Score
Distant Metastasis: spread of the cancer to areas outside the neck Yes 3
No 0
Age at the time the tumor was discovered Less than 39 years 3.1
Over 40 years 0.08 x age
Invasion into surrounding areas of the neck as seen by the naked eye Yes 1
No 0
Completeness of surgical resection (or removal) of the tumor Incomplete 1
Complete 0
Size of the tumor 0.3 x size in cm
Sum of MACIS score 20 yr Survival
< 6.0 99%
6.0 - 6.99 89%
7.0 - 7.99 56%
> 8.0 24%

Most patients fall into the low risk category (MACIS score less than 6.0) and are cured of the cancer at the time of surgery.

Children with multiple lung metastases and/or a miliary aspect still have an excellent long-term prognosis if given adequate treatment.

5 year Relative Survival Rate

  • 5 year relative survival rate of follicular thyroid cancer depends on the stage of the disease at the time of diagnosis.
  • Stage 1 has 100% 5 year relative survival rate
  • Stage 2 has 100% 5 year relative survival rate
  • Stage 3 has 93% 5 year relative survival rate
  • Stage 4 has 51% 5 year relative survival rate

References

  1. 1.0 1.1 Numbers from National Cancer Database in the US, from Page 10 in: Biersack, H-J; Grünwald, F (Eds) (2005). Thyroid Cancer. Berlin: Springer. ISBN 3-540-22309-6. (Note: Book also states that the 14 percent 10-year survival for anaplastic thyroid cancer was overestimated)
  2. Rounded up to nearest natural number from 96.7 percent as given by eMedicine > Thyroid, Papillary Carcinoma Author: Luigi Santacroce. Coauthors: Silvia Gagliardi and Andrew Scott Kennedy. Updated: Sep 28, 2010
  3. "New York Thyroid Center: Prognosis Staging for Thyroid Cancer". Retrieved 2007-12-22.
  4. New York Thyroid Center > Thyroid cancer > Prognosis staging Retrieved on April 30, 2010

References


Template:WikiDoc Sources